EICHORPublic-registry site landscape for NCT07578636, “A Study to Understand What the Body Does to the Study Medicine Called PF-07799544 When Taken by Healthy Adults”, a Healthy Male Volunteers study sponsored by Pfizer. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07578636 (registry record) |
| Study title | A Study to Understand What the Body Does to the Study Medicine Called PF-07799544 When Taken by Healthy Adults |
| Official title | A PHASE 1, OPEN-LABEL, FIXED SEQUENCE, 2-PERIOD STUDY IN HEALTHY ADULT PARTICIPANTS TO ASSESS THE MASS BALANCE, ABSOLUTE BIOAVAILABILITY, FRACTION ABSORBED, AND PHARMACOKINETICS OF [14C]PF-07799544 USING A 14C-MICROTRACER APPROACH |
| Sponsor | Pfizer |
| Condition(s) | Healthy Male Volunteers |
| Phase | PHASE1 |
| Listed sites | 1 |
| Site countries | United States |
At Fortrea Clinical Research Unit Inc. — one of the facilities listed on this trial — 1 other study is actively recruiting Healthy Male Volunteers patients at the same facility (public registry, as of July 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Patient-friendly overview of this study: eichor.com/study/NCT07578636.
Eichor generates a preliminary site-risk snapshot for NCT07578636 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
